FIRST TRACKS BIOTHERAPEUTICS SHARES HIT NEAR THREE-WEEK HIGH, LAST UP 21.7% AFTER POSITIVE RESULTS FROM CELIAC DISEASE DRUG TRIAL

Reuters · 3d ago

Please log in to view news